BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
BTC$60,654.00-0.59%
ETH$1,559.10-1.26%
USDT$0.9996-0.01%
BNB$573.34+0.04%
USDC$0.9997+0.01%
XRP$1.09-1.35%
SOL$61.91-3.12%
TRX$0.3237+0.86%
FIGR_HELOC$1.03+0.46%
DOGE$0.0814-0.42%
HYPE$56.44-5.27%
USDS$0.9997-0.02%
LEO$9.44-1.44%
RAIN$0.0128-1.63%
XLM$0.2116+5.14%
CC$0.1627+9.72%
The S&P 500 has rebounded dramatically from its April lows, gaining over 22% and reaching new record highs.
Nike's Q4 earnings beat lowered expectations with EPS of $0.14 vs $0.12 forecast and revenue of $11.1B vs $10.7B expected, driving premarket gains as analysts see…
Cathie Wood correctly identified our exposure analysis to nuclear, eVTOL, AI, CPUs and GPUs.
Cyngn stock soared nearly 100% in premarket trading following the announcement of its collaboration with NVIDIA.
The exit of the crypto-hostile Biden admin is unleashing a new era of digital payments.
FedEx shares drop in premarket after the company beats Q4 earnings but pulls annual outlook and provides weak Q1 guidance amid trade uncertainties.
QuantumScape shares are surging in premarket trading following the company's announcement that its advanced Cobra separator process has successfully entered baseline production.
Intel's stock jumped over 5% following news of major marketing workforce reductions and AI-driven outsourcing to Accenture.
Carnival Corporation shares jumped nearly 10% after the cruise operator posted impressive Q2 results that beat expectations across all key metrics.
SMCI recently doubled down on AI; what does this mean for shareholders?
Nektar Therapeutics stock surged 116% in premarket trading after announcing successful Phase 2b trial results for its atopic dermatitis treatment.
Tesla stock surged 10% after launching its robotaxi service in Austin with a $4.20 flat fee.
Novo Nordisk ended its month-old partnership with Hims & Hers Health over illegal drug compounding practices.